HCID 178429553, compound → HCID 15079183, compound
Reaction equation
[N:1]1[C:10]2[C:5](=[CH:6][CH:7]=[C:8]([C:11]3[CH:12]([CH3:18])[CH2:13][C:14](=[O:17])[NH:15][N:16]=3)[CH:9]=2)[CH2:4][NH:3][CH:2]=1>C(Cl)(Cl)Cl.[O-2].[O-2].[Mn+4]>[CH3:18][CH:12]1[C:11]([C:8]2[CH:9]=[C:10]3[C:5]([CH:4]=[N:3][CH:2]=[N:1]3)=[CH:6][CH:7]=2)=[N:16][NH:15][C:14](=[O:17])[CH2:13]1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
In 20 ml of chloroform was dissolved 0.25 g of Compound 71 obtained in Example 71, and 2.0 g of manganese dioxide was added to the solution, followed by stirring at room temperature for 1 hour. Insoluble substances were filtered off, and the filtrate was concentrated. The residue was crystallized by the addition of diethyl ether to give 0.2 g (83%) of 4,5-dihydro-5-methyl-6-(7-quinazolinyl)-3(2H)-pyridazinone (Compound 54).
Workup
- additionwas added to the solution
- filtrationInsoluble substances were filtered off
- concentrationthe filtrate was concentrated
- customThe residue was crystallized by the addition of diethyl ether
Sources & evidence
- ORD record
- ord-d8a799c6a6bb459180bbddfc50095549
- Source dataset
- uspto-grants-1991_11
- Patent number
- US05063227
Reaction notes
Loading…